careful, page-5

Re.: Oppies.
Look back at reports about 2 years ago and you will see that these options are in the hands of a couple of people i.e. Don Evans and friends (W.A.) who happen to be from the largest shareholders and supporters of the Company. They are unlisted options that expire 31 July 2009.

Very different to listed options where you get the normal ramp in share price prior to expiry date in order to get options exercised. Any increase in share price this time around has nothing to do with option exercise !! It has to do with fundamentals. We are now in the home straight with commercialisation just around the corner.

Another point to ponder about:

Major ATS conference starting this Friday in San Diego .

http://www.thoracic.org/sections/meetings-and-courses/international-conference/2009/index.html

We are pleased to invite you to attend ATS 2009 • San Diego, the International Conference of the American Thoracic Society. The ATS meeting is one of the largest gatherings of pulmonary and critical care clinicians and researchers in the world. Last year’s Conference in Toronto was attended by over 15,000 people from 90 countries, and we expect this year’s meeting in San Diego to be even more exciting and diverse. The Conference program will offer information on the latest and most significant developments in clinical practice, research (clinical, basic, and translational), health advocacy, and education.
ATS 2009 • San Diego will include topics such as obstructive sleep apnea, chronic obstructive pulmonary disease, lung cancer, multiple organ dysfunction, obesity and lung health, pleural infection, interstitial pulmonary fibrosis, and drug-resistant tuberculosis. The Clinical Year in Review, Clinical Topics in Pulmonary Medicine, and the Critical Care Track offer focused, in depth education. Scientific and translational sessions will examine genetics, the biology of hypoxia, airway remodeling, lung injury and repair, and pulmonary hypertension. The ATS presents a thriving, interactive venue for the presentation of original research, and last year 5,603 scientific abstracts were presented at the Conference. A major strength of our International Conference is the ability of clinicians and researchers to interact and to exchange ideas.

KSX have a large stand at the Trade Show and will be presenting at the sessions.